<SEC-DOCUMENT>0001571049-16-015681-index.html : 20160531
<SEC-HEADER>0001571049-16-015681.hdr.sgml : 20160531
<ACCEPTANCE-DATETIME>20160531163334
ACCESSION NUMBER:		0001571049-16-015681
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160526
FILED AS OF DATE:		20160531
DATE AS OF CHANGE:		20160531

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			UPRICHARD DAVID C
		CENTRAL INDEX KEY:			0001239916

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		161686310

	MAIL ADDRESS:	
		STREET 1:		12 PINE STREET
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19106
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>t1601438_x7-uprichard.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: t1601438_x7-uprichard.html

Document 1 - RAW XML: t1601438_x7-uprichard.xml

</DOCUMENT>
</SEC-DOCUMENT>